Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion
NCT ID: NCT07003204
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2025-05-11
2025-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Yield of Agitated Exudative Non-infected Pleural Effusion
NCT05819294
Evaluation and Outcome of Para-pneumonic Effusion
NCT03480490
Fluid Agitation Microbiologic Yield In Pleural Infection Feasibility Study
NCT05702580
Evaluation and Importance of the PD-1/PD-L1 and the IL-10/IL-10R Axis in Malignant and Benign Pleural Effusions - a Pilot Study
NCT04834830
Modified Thoracoscopic Pleural Cryobiopsy in Diagnosis of Exudative Pleural Effusion
NCT04683419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
only one group of patients
prospective cohort randomized control study
medical thoracoscopy
pleural fluid aspiration and cellular analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medical thoracoscopy
pleural fluid aspiration and cellular analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Sabry
Lecturer of chest diseases
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohamed Sabry eltarhony, lecturer
Role: PRINCIPAL_INVESTIGATOR
Alexandria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chest Department -Faculty of Medicine
Alexandria, Egypt, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Related Links
Access external resources that provide additional context or updates about the study.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8075197/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lymphocyte- monocyte- exudate
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.